Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fin Stolze Larsen
Julia Wendon

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Hepatology (Baltimore, Md.)|May 15, 2009
Alternative pathway therapy for hyperammonemia in liver failureFin Stolze Larsen, Julia Wendon
Intensive Care Medicine|April 17, 2014
Understanding paracetamol-induced liver failureFin Stolze Larsen, Julia Wendon
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2002
Brain edema in liver failure: basic physiologic principles and managementFin Stolze Larsen, Julia Wendon
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2008
Prevention and management of brain edema in patients with acute liver failureFin Stolze Larsen, Julia Wendon
Journal of Hepatology|April 29, 2015
Acute liver failure: A curable disease by 2024?William Bernal, William M Lee, Julia Wendon, et al.
Hepatology (Baltimore, Md.)|March 9, 2011
Hypermagnesemia does not prevent intracranial hypertension and aggravates cerebral hyperperfusion in a rat model of acute hyperammonemiaPeter Nissen Bjerring, Martin Eefsen, Fin Stolze Larsen, et al.
Journal of Hepatology|June 4, 2016
Reply to: "High volume plasma exchange in patients with acute liver failure"Fin Stolze Larsen
Metabolic Brain Disease|February 27, 2003
Cerebral blood flow in hyperammonemia: heterogeneity and starling forces in capillariesFin Stolze Larsen
Neurocritical Care|February 10, 2007
Is it worthwhile to use cerebral microdialysis in patients with acute liver failure?Fin Stolze Larsen
Hepatology (Baltimore, Md.)|February 10, 2004
Optimal management of patients with fulminant hepatic failure: targeting the brainFin Stolze Larsen
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Hepatology (Baltimore, Md.)|May 15, 2009
Alternative pathway therapy for hyperammonemia in liver failureFin Stolze Larsen, Julia Wendon
Intensive Care Medicine|April 17, 2014
Understanding paracetamol-induced liver failureFin Stolze Larsen, Julia Wendon
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2002
Brain edema in liver failure: basic physiologic principles and managementFin Stolze Larsen, Julia Wendon
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2008
Prevention and management of brain edema in patients with acute liver failureFin Stolze Larsen, Julia Wendon
Journal of Hepatology|April 29, 2015
Acute liver failure: A curable disease by 2024?William Bernal, William M Lee, Julia Wendon, et al.
Hepatology (Baltimore, Md.)|March 9, 2011
Hypermagnesemia does not prevent intracranial hypertension and aggravates cerebral hyperperfusion in a rat model of acute hyperammonemiaPeter Nissen Bjerring, Martin Eefsen, Fin Stolze Larsen, et al.
Journal of Hepatology|June 4, 2016
Reply to: "High volume plasma exchange in patients with acute liver failure"Fin Stolze Larsen
Metabolic Brain Disease|February 27, 2003
Cerebral blood flow in hyperammonemia: heterogeneity and starling forces in capillariesFin Stolze Larsen
Neurocritical Care|February 10, 2007
Is it worthwhile to use cerebral microdialysis in patients with acute liver failure?Fin Stolze Larsen
Hepatology (Baltimore, Md.)|February 10, 2004
Optimal management of patients with fulminant hepatic failure: targeting the brainFin Stolze Larsen
Pageof 22